News Release
April 7, 2022
Showing 121 - 130 of 2593 results
Policy Snapshot
June 23, 2025
CMS Updates Nursing Home Care Compare
CMS is implementing several updates to the Nursing Home Care Compare website.
Policy Snapshot
January 12, 2026
CMS Updates Nursing Home Care Compare Following iQIES Transition
The Centers for Medicare & Medicaid Services (CMS) has released Quality & Safety Special Alert Memo QSSAM-26-01-NH to explain recent changes to Nursing Home Care Compare related to the transition to the Internet Quality Improvement and Evaluation System (iQIES). This modernization effort aims to en...
JAMDA
October 31, 2019
The Minimum Data Set Agitated and Reactive Behavior Scale: Measuring Behaviors in Nursing Home Residents With Dementia
Interventions aimed at managing agitated and aggressive behaviors in dementia without the use of antipsychotics are currently being tested in nursing homes (NHs). Researchers and clinicians require a measure that can capture the severity of residents’ behaviors. We test the internal consistency and constru...
JAMDA
April 20, 2023
Potentially Harmful Medication Prescribing by the Degree of Physician Specialization in Nursing Home Practice: An Observational Study
The use of anticholinergics, antipsychotics, benzodiazepines, and other potentially harmful medications (PHMs) is associated with particularly poor outcomes in nursing home (NH) residents with Alzheimer's disease and related dementias (ADRD). Our objective was to compare PHM prescribing by NH physicia...
JAMDA
December 28, 2020
To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living?
In nursing homes (NHs), psychoactive medication use has received notable attention, but less is known about prescribing in assisted living (AL). This study examined how antipsychotic and antianxiety medication prescribing in AL compares with NHs.
JAMDA
September 26, 2018
Quality Clinical Care in Nursing Facilities
Despite improvements in selected nursing facility (NF) quality measures such as reduction in antipsychotic use; local, state, and national initiatives; and regulatory incentives, the quality of clinical care delivered in this setting remains inconsistent. Herein, recommendations for overcoming barriers to ...
JAMDA
July 20, 2021
Racial Disparities in COVID-19 Vaccine Acceptance: Building Trust to Protect Nursing Home Staff and Residents
Vaccines are critical to protect both nursing home residents and staff from COVID-19, but some staff have expressed reservations about being vaccinated. In this brief report, we describe interventions that Genesis HealthCare—one of the largest US long-term care providers—implemented after recognizing midwa...
JAMDA
May 11, 2022
Deficiency Citations on Inappropriate Psychotropics Use Related to Care for Behavioral Symptoms of Dementia
The Centers for Medicare and Medicaid (CMS) initiated the National Partnership to Improve Dementia Care in Nursing Homes in 2012, which helped decrease antipsychotics use. However, inappropriate use of antipsychotics and other psychotropic medications to control behavioral symptoms associated with dementia...
JAMDA
May 20, 2023
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
The use of antipsychotics in persons with Parkinson's disease (PD) is common, although their use may aggravate the symptoms of PD. Clozapine and quetiapine are the only antipsychotics recommended in PD treatment guidelines. Information on factors associated with initiation of antipsychotics is needed....
